Prognostic Value of TACE With Irinotecan-loaded Drug-eluting Beads (DEBIRI) in Patients With Liver Metastases from Unresectable Colorectal Cancer.

Toru IshikawaMichitaka ImaiRyo SatoRyo JimboYuji KobayashiToshifumi SatoAkito IwanagaTomoe SanoJunji YokoyamaTerasu Honma

Published in: Anticancer research (2023)

TACE with DEBIRI may improve the prognosis of patients with liver metastases from unresectable colorectal cancer. We suggest that TACE with DEBIRI should be highly considered, especially in patients in whom liver metastasis may be a prognostic factor.

Keyphrases

liver metastases
prognostic factors
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
drug delivery
squamous cell carcinoma
patient reported outcomes
rectal cancer
locally advanced